| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/21/2004 | EP0759772B1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 01/21/2004 | EP0667786B1 Retro-, inverso-, and retro-inverso synthetic peptide analogues |
| 01/21/2004 | CN1469931A Plant-signalling ligand like proteins |
| 01/21/2004 | CN1469929A Method of modifying microorganism-origin transglutaminase |
| 01/21/2004 | CN1469927A Enhancemnet of industrial production by increasing substrate transport |
| 01/21/2004 | CN1469926A Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/21/2004 | CN1469883A Peptide selection method |
| 01/21/2004 | CN1469755A Vaccines containing ribavirin and methods of use thereof |
| 01/21/2004 | CN1469754A Orally administered peptides to ameliorate a therosclerosis |
| 01/21/2004 | CN1468958A Synthesis and high-efficiency expression method of bivalent foot-and-mouth disease polypeptide vaccine |
| 01/21/2004 | CN1468864A New monomeric insulin and its medicinal composition and prepn process |
| 01/21/2004 | CN1468863A Polyglycol-human growth hormone conjugate and its prepn process and medicinal use |
| 01/21/2004 | CN1468862A Technological process of producing recombinant human histiotype plasminogen activator TNK mutant |
| 01/21/2004 | CN1468861A Recombinant human immune deficiency virus fusion inhibitor and its prepn and use |
| 01/21/2004 | CN1135236C 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/21/2004 | CN1135235C Method for extracting prion protein and reagent kit |
| 01/20/2004 | US6680427 Chimeric gene encoding mlo-like polypeptide in sense or antisense orientation; gene expression, engineering; fungal diseases in plants |
| 01/20/2004 | US6680424 Modified proteinase inhibitors |
| 01/20/2004 | US6680380 Nucleic acids encoding mammalian interleukin-1ζ, related reagents and methods |
| 01/20/2004 | US6680379 Drug screening; cell cultures |
| 01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
| 01/20/2004 | US6680373 Polypeptide for use in the human diagnostics and therapeutics |
| 01/20/2004 | US6680372 Antibodies specific for growth differentiation factor-7 |
| 01/20/2004 | US6680371 Myc homology region II-associated protein and uses thereof |
| 01/20/2004 | US6680370 Diagnosing defective mesangial cells; glomerulosclerosis, nephritis, and diabetic nephropathy treatment |
| 01/20/2004 | US6680369 Nucleotide sequences coding protein for use in treatment cytoskeletal defects |
| 01/20/2004 | US6680368 Protein encoded by dna |
| 01/20/2004 | US6680367 Light emitting compounds; probes; receptor binding assays |
| 01/20/2004 | US6680366 Detecting antibodies; drug screening; genetic engineering |
| 01/20/2004 | US6680298 Administering polypeptide to increase serum levels; dietetics, hypoglycemic agents; cardiovascular, autoimmune, kidney, metabolic and nervous system disorder treatment |
| 01/20/2004 | US6680297 Mammalian growth factor |
| 01/20/2004 | US6680296 Compositions comprising bouganin and a cell binding ligand are particularly useful to kill cells of a target population |
| 01/20/2004 | US6680291 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 01/20/2004 | US6680207 Detection of molecules in samples |
| 01/20/2004 | US6680197 Breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, and t cells that are specific for cells expressing such polypeptides. |
| 01/20/2004 | US6680196 Pd2 gene and its encoded protein for differential diagnosis and therapy of pancreatic adenocarcinomas |
| 01/20/2004 | US6680195 Extracellular matrix-binding proteins from staphylococcus aureus |
| 01/20/2004 | US6680191 Isolated nucleic acid molecules coding for tumor rejection antigen precursors of members of the MAGE-C and MAGE-B FAMILIES and uses thereof |
| 01/20/2004 | US6680182 Promoter sequence operably linked to a dna sequence encoding first and second proteins linked by hinge regiion; tetanus toxin c fragments |
| 01/20/2004 | US6680181 Production of peptides |
| 01/20/2004 | US6680180 Kv6.2, a voltage-gated potassium channel subunit |
| 01/20/2004 | US6680175 Diagnosing cancer in humans; obtain biopsy of human tissue, detect and measure signal from bound polypeptide marker, evaluate humans for cancer |
| 01/20/2004 | US6680173 Diagnosis of tauopathies |
| 01/20/2004 | US6680171 Drug screening, genetic engineering |
| 01/20/2004 | US6680168 Passive immunization against clostridium difficile disease |
| 01/20/2004 | US6680167 Molecules of the card-related protein family and uses thereof |
| 01/20/2004 | US6680061 Isolated hydrophilic polypeptide inducing protection against eimeria infection in poultry |
| 01/20/2004 | US6680060 A live hepatitis a virus adapted to growth in mrc-5 cells (human fibroblast-like cell line) |
| 01/20/2004 | US6680059 Vaccines containing ribavirin and methods of use thereof |
| 01/20/2004 | US6680058 Compositions and methods for contraception in or sterilization of mammals |
| 01/20/2004 | US6680057 Using protein comprising partial amino acid sequence 2 or 10 |
| 01/20/2004 | US6680056 Stimulating proliferation of cytolytic t cells |
| 01/20/2004 | US6680054 Macromolecular neuraminidase-binding compounds |
| 01/20/2004 | CA2148599C Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them |
| 01/20/2004 | CA2115414C Technique for extracorporeal treatment of blood |
| 01/20/2004 | CA2101534C Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 01/20/2004 | CA2090961C Specific binding agents |
| 01/20/2004 | CA2089212C Antibodies to human gastrin-releasing peptide precusor and use thereof |
| 01/20/2004 | CA2083027C Formation of protein microparticles by antisolvent precipitation |
| 01/16/2004 | CA2432968A1 Novel g proteins, polynucleotide encoding the same and utilization thereof |
| 01/15/2004 | WO2004005931A1 Secreted polypeptide species associated with cardiovascular disorders |
| 01/15/2004 | WO2004005923A1 RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 01/15/2004 | WO2004005892A2 Antimicrobial activity of interferon-inducible elr chemokines |
| 01/15/2004 | WO2004005887A2 Methods and compositions for the detection of pregnancy in ruminants |
| 01/15/2004 | WO2004005555A1 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
| 01/15/2004 | WO2004005541A1 Diagnostic tests for the detection of peripheral neuropathy |
| 01/15/2004 | WO2004005530A2 Compositions and methods for treatment and detection of multiple cancers |
| 01/15/2004 | WO2004005529A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/15/2004 | WO2004005524A1 Hepatitis c virus particle formation |
| 01/15/2004 | WO2004005521A1 Expression of the human igf-1 in transgenic plastids |
| 01/15/2004 | WO2004005520A1 Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants |
| 01/15/2004 | WO2004005515A1 Sterility recovery genes to rice bt type male sterile cytoplasm |
| 01/15/2004 | WO2004005514A1 Human protooncogene 6 and protein encoded therein |
| 01/15/2004 | WO2004005512A1 Nove protein and use thereof |
| 01/15/2004 | WO2004005511A1 Tumor-lysing virus growing selectively in tumor cells |
| 01/15/2004 | WO2004005510A1 NOVEL Nogo RECEPTOR-LIKE POLYPEPTIDE AND DNA THEREOF |
| 01/15/2004 | WO2004005509A1 Method of examining allergic disaese and drug for treating the same |
| 01/15/2004 | WO2004005502A1 Programmed cell death used as a biological containment system |
| 01/15/2004 | WO2004005498A1 Chimeric gb virus b (gbv-b) |
| 01/15/2004 | WO2004005497A1 Method of screening insulin resistance improving drug |
| 01/15/2004 | WO2004005495A1 Novel airway epithelial cell line and use thereof |
| 01/15/2004 | WO2004005491A1 Genetically modified microorganisms, plasmid and fermentation process with the presence of flocculation regulated by medium changes |
| 01/15/2004 | WO2004005489A2 Nucleic acids encoding sarcocystic neurona antigen and uses thereof |
| 01/15/2004 | WO2004005486A2 Mp21s as modifiers of the p21 pathway and methods of use |
| 01/15/2004 | WO2004005485A2 Compositions and methods for controlling parasitic nematodes |
| 01/15/2004 | WO2004005481A2 Methods for identifying modulators of mda-7 mediated apoptosis |
| 01/15/2004 | WO2004005480A2 Plastid genetic engineering via somatic embryogenesis |
| 01/15/2004 | WO2004005473A2 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | WO2004005472A2 Inhibitors of ftsz and uses thereof |
| 01/15/2004 | WO2004005469A2 Peptides from the e2, e6 and e7 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other cancers |
| 01/15/2004 | WO2004005468A2 Axs gene and protein and methods related thereto |
| 01/15/2004 | WO2004005467A2 Expression of human interferon in transgenic chloroplasts |
| 01/15/2004 | WO2004005463A2 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer |
| 01/15/2004 | WO2004005346A2 Human nuclear hormone receptor |
| 01/15/2004 | WO2004005345A1 Inhibitors of the ephrin/ephb receptor interaction |
| 01/15/2004 | WO2004005344A1 Ligand binding domains of nuclear hormone receptors |
| 01/15/2004 | WO2004005343A1 Production of transformed plants expressing thyroid stimulating hormone receptor |
| 01/15/2004 | WO2004005341A2 Full-length interferon gamma polypeptide variants |
| 01/15/2004 | WO2004005340A1 Fusion polypeptide comprising epidermal growth factor and human serum albumin |
| 01/15/2004 | WO2004005339A2 Cationic linear peptides having antibacterial and/or antifungal properties |